Toll-like receptor 4 ablation improves stem cell survival after hypoxic injury

Benjamin D. Brewster, Joshua D. Rouch, Meijing Wang, Daniel R. Meldrum

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction: Mesenchymal stem cell (MSC) therapy improves cardiac function after ischemia/reperfusion injury, but its effectiveness is limited by MSC survival in hypoxic environments. Toll-like receptor 4 (TLR4) contributes to pro-apoptotic signaling under hypoxic conditions. Activation of intracellular AKT and ERK pathways opposes this signal and improves cell survival. It is unknown whether ablation of TLR4 affects these pathways after hypoxic injury in MSCs. We hypothesized that: 1) TLR4 knockout (TLR4KO) in MSCs improves survival after hypoxic injury; and 2) this survival difference is due to improved signaling in the AKT and ERK pathways. Materials and methods: Murine wild-type (WT) and TLR4KO MSCs were harvested from bone marrow and grown in vitro. A total of 0.1 × 106 cells/well were incubated in hypoxic conditions versus normoxic controls. After 24 h, these groups were examined for cell survival via counting and compared using a t-test with P < 0.05 = statistical significance. AKT and ERK concentrations were measured in lysate using Western blot analysis. Results: The morphology of WT and TLR4KO MSCs was similar. In line with our previous findings, hypoxia did significantly increase cell death in WT cells (1.79 × 105 living cells/mL control versus 0.88 × 105 hypoxia, P < 0.05). Hypoxic injury did not increase cell death in the TLR4KO group (1.68 × 105 control versus 1.82 × 105 hypoxia, P < 0.05). Increased AKT activation was observed in all TLR4KO groups. TLR4 did not affect phosphorylated ERK levels. Conclusion: TLR4-knockout MSCs show improved survival after hypoxic injury because of increased AKT pathway signal. Use of TLR4-knockout MSCs in ischemia/reperfusion studies results in enhanced cardioprotection; improved stem cell survival was likely a contributing factor.

Original languageEnglish
Pages (from-to)330-333
Number of pages4
JournalJournal of Surgical Research
Volume177
Issue number2
DOIs
StatePublished - Oct 2012

Fingerprint

Toll-Like Receptor 4
Cell Survival
Stem Cells
Wounds and Injuries
MAP Kinase Signaling System
Mesenchymal Stromal Cells
Cell Death
Cell- and Tissue-Based Therapy
Reperfusion Injury
Reperfusion
Signal Transduction
Ischemia
Bone Marrow
Western Blotting
Hypoxia

Keywords

  • Hypoxia
  • Mesenchymal stem cells
  • TLR4
  • Toll-like receptor

ASJC Scopus subject areas

  • Surgery

Cite this

Toll-like receptor 4 ablation improves stem cell survival after hypoxic injury. / Brewster, Benjamin D.; Rouch, Joshua D.; Wang, Meijing; Meldrum, Daniel R.

In: Journal of Surgical Research, Vol. 177, No. 2, 10.2012, p. 330-333.

Research output: Contribution to journalArticle

Brewster, Benjamin D. ; Rouch, Joshua D. ; Wang, Meijing ; Meldrum, Daniel R. / Toll-like receptor 4 ablation improves stem cell survival after hypoxic injury. In: Journal of Surgical Research. 2012 ; Vol. 177, No. 2. pp. 330-333.
@article{0954d6704a9b425796781f26707d9678,
title = "Toll-like receptor 4 ablation improves stem cell survival after hypoxic injury",
abstract = "Introduction: Mesenchymal stem cell (MSC) therapy improves cardiac function after ischemia/reperfusion injury, but its effectiveness is limited by MSC survival in hypoxic environments. Toll-like receptor 4 (TLR4) contributes to pro-apoptotic signaling under hypoxic conditions. Activation of intracellular AKT and ERK pathways opposes this signal and improves cell survival. It is unknown whether ablation of TLR4 affects these pathways after hypoxic injury in MSCs. We hypothesized that: 1) TLR4 knockout (TLR4KO) in MSCs improves survival after hypoxic injury; and 2) this survival difference is due to improved signaling in the AKT and ERK pathways. Materials and methods: Murine wild-type (WT) and TLR4KO MSCs were harvested from bone marrow and grown in vitro. A total of 0.1 × 106 cells/well were incubated in hypoxic conditions versus normoxic controls. After 24 h, these groups were examined for cell survival via counting and compared using a t-test with P < 0.05 = statistical significance. AKT and ERK concentrations were measured in lysate using Western blot analysis. Results: The morphology of WT and TLR4KO MSCs was similar. In line with our previous findings, hypoxia did significantly increase cell death in WT cells (1.79 × 105 living cells/mL control versus 0.88 × 105 hypoxia, P < 0.05). Hypoxic injury did not increase cell death in the TLR4KO group (1.68 × 105 control versus 1.82 × 105 hypoxia, P < 0.05). Increased AKT activation was observed in all TLR4KO groups. TLR4 did not affect phosphorylated ERK levels. Conclusion: TLR4-knockout MSCs show improved survival after hypoxic injury because of increased AKT pathway signal. Use of TLR4-knockout MSCs in ischemia/reperfusion studies results in enhanced cardioprotection; improved stem cell survival was likely a contributing factor.",
keywords = "Hypoxia, Mesenchymal stem cells, TLR4, Toll-like receptor",
author = "Brewster, {Benjamin D.} and Rouch, {Joshua D.} and Meijing Wang and Meldrum, {Daniel R.}",
year = "2012",
month = "10",
doi = "10.1016/j.jss.2012.04.042",
language = "English",
volume = "177",
pages = "330--333",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Toll-like receptor 4 ablation improves stem cell survival after hypoxic injury

AU - Brewster, Benjamin D.

AU - Rouch, Joshua D.

AU - Wang, Meijing

AU - Meldrum, Daniel R.

PY - 2012/10

Y1 - 2012/10

N2 - Introduction: Mesenchymal stem cell (MSC) therapy improves cardiac function after ischemia/reperfusion injury, but its effectiveness is limited by MSC survival in hypoxic environments. Toll-like receptor 4 (TLR4) contributes to pro-apoptotic signaling under hypoxic conditions. Activation of intracellular AKT and ERK pathways opposes this signal and improves cell survival. It is unknown whether ablation of TLR4 affects these pathways after hypoxic injury in MSCs. We hypothesized that: 1) TLR4 knockout (TLR4KO) in MSCs improves survival after hypoxic injury; and 2) this survival difference is due to improved signaling in the AKT and ERK pathways. Materials and methods: Murine wild-type (WT) and TLR4KO MSCs were harvested from bone marrow and grown in vitro. A total of 0.1 × 106 cells/well were incubated in hypoxic conditions versus normoxic controls. After 24 h, these groups were examined for cell survival via counting and compared using a t-test with P < 0.05 = statistical significance. AKT and ERK concentrations were measured in lysate using Western blot analysis. Results: The morphology of WT and TLR4KO MSCs was similar. In line with our previous findings, hypoxia did significantly increase cell death in WT cells (1.79 × 105 living cells/mL control versus 0.88 × 105 hypoxia, P < 0.05). Hypoxic injury did not increase cell death in the TLR4KO group (1.68 × 105 control versus 1.82 × 105 hypoxia, P < 0.05). Increased AKT activation was observed in all TLR4KO groups. TLR4 did not affect phosphorylated ERK levels. Conclusion: TLR4-knockout MSCs show improved survival after hypoxic injury because of increased AKT pathway signal. Use of TLR4-knockout MSCs in ischemia/reperfusion studies results in enhanced cardioprotection; improved stem cell survival was likely a contributing factor.

AB - Introduction: Mesenchymal stem cell (MSC) therapy improves cardiac function after ischemia/reperfusion injury, but its effectiveness is limited by MSC survival in hypoxic environments. Toll-like receptor 4 (TLR4) contributes to pro-apoptotic signaling under hypoxic conditions. Activation of intracellular AKT and ERK pathways opposes this signal and improves cell survival. It is unknown whether ablation of TLR4 affects these pathways after hypoxic injury in MSCs. We hypothesized that: 1) TLR4 knockout (TLR4KO) in MSCs improves survival after hypoxic injury; and 2) this survival difference is due to improved signaling in the AKT and ERK pathways. Materials and methods: Murine wild-type (WT) and TLR4KO MSCs were harvested from bone marrow and grown in vitro. A total of 0.1 × 106 cells/well were incubated in hypoxic conditions versus normoxic controls. After 24 h, these groups were examined for cell survival via counting and compared using a t-test with P < 0.05 = statistical significance. AKT and ERK concentrations were measured in lysate using Western blot analysis. Results: The morphology of WT and TLR4KO MSCs was similar. In line with our previous findings, hypoxia did significantly increase cell death in WT cells (1.79 × 105 living cells/mL control versus 0.88 × 105 hypoxia, P < 0.05). Hypoxic injury did not increase cell death in the TLR4KO group (1.68 × 105 control versus 1.82 × 105 hypoxia, P < 0.05). Increased AKT activation was observed in all TLR4KO groups. TLR4 did not affect phosphorylated ERK levels. Conclusion: TLR4-knockout MSCs show improved survival after hypoxic injury because of increased AKT pathway signal. Use of TLR4-knockout MSCs in ischemia/reperfusion studies results in enhanced cardioprotection; improved stem cell survival was likely a contributing factor.

KW - Hypoxia

KW - Mesenchymal stem cells

KW - TLR4

KW - Toll-like receptor

UR - http://www.scopus.com/inward/record.url?scp=84866024490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866024490&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2012.04.042

DO - 10.1016/j.jss.2012.04.042

M3 - Article

C2 - 22703984

AN - SCOPUS:84866024490

VL - 177

SP - 330

EP - 333

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -